ApproaCH was a randomized, double-blind, placebo-controlled trial evaluating TransCon CNP in 84 children with achondroplasia ages 2-11, randomized 2:1 to receive TransCon CNP at the 100 μg/kg/week ...
Ascendis Pharma (ASND) announced that pivotal Week 52 results from its randomized double-blind, placebo-controlled ApproaCH Trial of ...
A tailored approach with rapid needs assessment before and during implementation to address local testing site barriers in ...
Before new therapies can reach patients, they must be tested in clinical trials in representative populations to show that they work and are safe. Failure to enroll enough participants in trials can ...
A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us.
What makes this trial different is that it’s one of the first to adopt a ‘pragmatic’ approach. Pragmatic clinical trials (PCTs) are designed to evaluate the effectiveness of therapeutic interventions ...
New Approach to Clinical Trial Design Helps Medical Devices Better Meet Patient Needs and Priorities
ARLINGTON, Va.--(BUSINESS WIRE)--A Medical Device Innovation Consortium (MDIC) program today released a new framework that provides U.S. medical device companies a systematic approach for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback